In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...

Double Scorpio, a popular manufacturer of these products, posted a notice to its website, reading: “Double Scorpio has ...

Scientists discovered genes in the tuberculosis bacterium that becomes essential for the pathogen's survival when it's exposed to air through coughing. These genes could be targets for new therapies ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Toothpaste plays a key role in oral health by breaking up bacterial biofilm, reducing the risk of tooth decay and gum disease. While some ingredients may affect the oral microbiome, research suggests ...

Tuberculosis lives and thrives in the lungs. When the bacteria that cause the disease are coughed into the air, they are ...

A journey through the front lines of global poverty shows that when the world’s richest men slash aid for the world’s poorest ...

Without public health surveillance, officials trying to tackle outbreaks, identify threats and evaluate treatments are working ‘in the darkness of ignorance.’ ...

New research into how a retrovirus is spreading across populations of wild koalas in Queensland, Australia is leading to a ...